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NEW FINDINGS 
WHAT IS THE CENTRAL QUESTION OF THIS STUDY? 
Compared with Caucasians, African individuals are more susceptible to non-freezing cold injury and 
experience greater cutaneous vasoconstriction and cooler finger skin temperatures upon hand cooling. 
We investigated whether the enzyme cyclooxygenase is, in part, responsible for the exaggerated 
response to local cooling. 
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WHAT IS THE MAIN FINDING AND ITS IMPORTANCE? 
During local hand cooling, African descent individuals experienced significantly lower finger skin 
blood flow and skin temperature compared with Caucasians irrespective of cyclooxygenase inhibition. 
These data suggest that in young African males the cyclooxygenase pathway appears not to be the 
primary reason for the increased susceptibility to non-freezing cold injury. 
 
ABSTRACT 
African descent (AFD) individuals are more susceptible to non-freezing cold injury (NFCI) and 
experience an exaggerated cutaneous vasoconstrictor response to hand cooling compared with 
Caucasians (CAU). Using a placebo-controlled, crossover design, this study tested the hypothesis that 
cyclooxygenase (COX) may, in part, be responsible for the exaggerated vasoconstrictor response to 
local cooling in AFD. Twelve AFD and twelve CAU young healthy males completed foot cooling and 
hand cooling (separately, in 8 °C water for 30 minutes) with spontaneous rewarming in 30 °C air 
following placebo or aspirin (COX inhibition) treatment. Skin blood flow, expressed as cutaneous 
vascular conductance (CVC, flux•mmHg-1), and skin temperature (Tsk) were measured throughout. 
Irrespective of COX inhibition, the responses to foot cooling, but not hand cooling, were similar 
between ethnicities. Specifically, during hand cooling following placebo, AFD experienced a lower 
minimum skin blood flow (0.5 [0.1] vs. 0.8 [0.2] flux•mmHg-1, P < 0.001) and a lower minimum 
finger Tsk (9.5 [1.4] °C vs. 10.7 [1.3] °C, P = 0.039) compared with CAU. During spontaneous 
rewarming average skin blood flow was also lower in AFD than CAU (2.8 [1.6] vs. 4.3 [1.0] 
flux•mmHg-1, P < 0.001). These data provide further support that AFD experience an exaggerated 
response to hand cooling and thus NFCI; however, the results demonstrate the COX pathway is not 
the primary reason for the exaggerated responses in AFD and increased susceptibility to NFCI.  
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LIST OF ABBREVIATIONS 
AFD African descent 
AUC  Area under curve 
CAU Caucasian 
COX Cyclooxygenase 
CVC Cutaneous vascular conductance 
IQR Interquartile range 
LDU  Laser Doppler units 
MAP Mean arterial pressure 
NFCI Non-freezing cold injury 
ROS Reactive oxygen species 
TXA2
 
Thromboxane A2  
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INTRODUCTION 
On initial whole-body cold exposure there is an immediate decrease in skin temperature (Tsk) which 
elicits local and centrally-induced constriction of the cutaneous circulation which serves as a defence 
mechanism, preventing heat loss from the body in an attempt to delay the onset of hypothermia 
(Spealman, 1945; Granberg, 1991; Kenney & Armstrong, 1996). In exchange for the protection of 
deep body temperature an individual is at risk of other cold injuries such as non-freezing cold injury 
(NFCI), with the feet more susceptible than the hands (Ungley & Blackwood, 1942). Symptoms of 
this injury often include pain, whilst mild cooling of the affected extremity is associated with an 
exaggerated vasoconstrictor response and slow rewarming which may leave an individual prone to 
further cold injuries. These symptoms may last for the remaining lifetime of an individual (Ungley et 
al., 1945). 
 
In the military population, particularly during conflict, cold injuries have resulted in hundreds of 
thousands of casualties (Paton, 2001; Golden et al., 2013). In the UK Armed Forces, between 2006 
and 2016, there were 1,235 successful personnel compensation claims for NFCI, with the most recent 
year (March 2015–2016) costing the Ministry of Defence £1,486,200. However, NFCI is not solely a 
military problem as cases have been reported in civilians (Ramstead et al., 1980; Wrenn, 1991) and 
those who expose themselves to cold during leisure activities, such as mountaineering or cold 
expeditions (O‟Brien & Frykman, 2003). Recently „Sport England‟ (2016) reported nearly 1.5 million 
individuals participate each month in sports which may involve cold exposure such as angling, water 
sports, mountaineering and snow sports, therefore the risk of NFCI is ever-present. 
 
A major predisposing risk factor on the incidence of NFCI is ethnicity. Individuals of African descent 
(AFD) are more susceptible to cold injuries compared with Caucasian individuals (CAU) under the 
same environmental conditions (DeGroot et al., 2003; Burgess & Macfarlane, 2009). Within the 
United States Armed Forces between 2009 and 2014 there were 3,008 individuals who suffered a cold 
injury, with AFD injured at twice the rate of CAU (Connor, 2014). Despite increased awareness and 
education, NFCI and other cold injuries remain a current issue. 
 
The mechanism(s) for the increased incidence of NFCI in AFD is not clear at present. During local 
hand cooling (8 °C for 30 minutes) and spontaneous rewarming we have previously observed that 
AFD experience greater vasoconstriction and also rewarm later and more slowly than CAU (Maley et 
al., 2014). The comparatively lower skin blood flow and lower Tsk in AFD may explain the increased 
susceptibility to NFCI. In addition we have shown that AFD appear to have a reduced endothelial 
function, showing a smaller vasodilatory response to ACh compared with CAU (Maley et al., 2015, 
2017); however, the reason for the differences in response to local cooling remains unclear.  
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During local cooling the decrease in skin blood flow is a result of sympathetic adrenergic activation 
releasing noradrenaline acting on post-synaptic adrenergic receptors (Pergola et al., 1993; Johnson et 
al., 2005), as well as an inhibition of nitric oxide production and contributions from non-adrenergic 
pathways (Hodges et al., 2006; Thompson-Torgerson et al., 2007; Johnson et al., 2014). Furthermore, 
cooling increases reactive oxygen species (ROS) (Bailey et al., 2005) which, along with reducing the 
bioavailability of nitric oxide, leads to translocation of α2C
 
receptors to the cell surface, capable of 
exaggerating the response to local cooling (Chotani et al., 2000, 2004). Compared with CAU, in vivo 
and in vitro data demonstrates AFD experience heightened oxidative stress and reduced 
bioavailability of nitric oxide (Kalinowski et al., 2004; Feairheller et al., 2011). This oxidative stress 
may be produced from various sources such as nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase and cyclooxygenase (COX) (Kukreja et al., 1986; Griendling & FitzGerald, 2003; 
Vanhoutte, 2011). Along with other prostanoids, COX produces TXA2, a vasoconstrictor which plays 
a role in the cold-induced vasoconstriction in response to hand cooling in those with Raynaud‟s 
phenomenon (Tindall et al., 1985), demonstrating TXA2 may play a role in those with altered vascular 
function. Coupled with the information that AFD experience greater levels of oxidative stress, perhaps 
produced through COX, and that COX increases ROS and produces TXA2, it is possible that this 
enzyme may contribute to the accentuated vasoconstrictor response in AFD during local cooling.  
 
Therefore, the aim of the present study was to determine whether the accentuated vasoconstrictor 
response during local cooling and the delayed release during rewarming in AFD involves the COX 
pathway. It was hypothesised that COX inhibition would attenuate the local cooling induced 
vasoconstriction and result in AFD experiencing local vascular responses similar to CAU. 
 
METHODS 
This study was given a favourable ethical opinion from the University of Portsmouth Science Faculty 
Ethics Committee and complied with standards set in „The Declaration of Helsinki‟ (October 2013). 
The participants were made aware of the purpose, procedures and risks of the study prior to giving 
their informed written consent. Twelve CAU and 12 AFD male volunteers participated in the study; 
their physical characteristics are presented in Table 1. 
 
All CAU were born in the UK. Eight AFD were born in the UK whilst four were born in Africa 
(Zimbabwe, Ghana, Kenya and Uganda) and had resided in the UK for an average of 11 years, with a 
minimum of seven years. All participants were non-smokers, were free from asthma and any vascular 
or blood disorders including hypertension, diabetes and Raynaud's phenomenon, with no history of 
either freezing or non-freezing cold injuries. Participants‟ history of cold exposure was ascertained by 
questionnaire with each ethnic group reporting similar exposure to cold. Ethnicity was determined by 
self-classification. To minimise heterogeneity, participants were only recruited if both parents and all 
four grandparents had known to originate from the same ethnic group. Prior to testing, participants 
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were asked to refrain from consuming alcohol for 24 hours and participating in exercise or consuming 
caffeine for 12 hours. 
 
EXPERIMENTAL PROCEDURES AND MEASUREMENTS 
In a balanced, cross-over, placebo controlled design, participants were required to attend the 
laboratory on two separate occasions at the same time of day. Both visits included immersion of the 
foot and hand, separately, into cold water. As we previously observed no ethnic differences in Tsk
 
and 
skin blood flow between ethnic groups in response to foot immersion in 15 °C water for two minutes 
(Maley et al., 2014), we decided to employ a cold-induced vasodilatation (CIVD) protocol, previously 
utilised (Maley et al., 2014), consisting of immersion in water at 8 °C for 30 minutes for both the foot 
and hand cooling. Previous research has demonstrated greater reactivity and comfort to 8 °C water 
compared with colder water (Mekjavic et al., 2013; Tyler et al., 2015). For every participant, foot 
cooling was performed first followed by hand cooling. 
 
Immediately prior to entering the climate controlled chamber participants were asked to consume 150 
mL of diluted orange squash with or without soluble aspirin (acetylsalicylic acid; 600 mg, Boots Inc., 
UK), blinded to the participant. Aspirin irreversibly inhibits COX by acetylation of the active site of 
COX (Vane, 1971) with this dose of aspirin shown to inhibit 86 % of bradykinin-induced production 
of prostacyclin and 99 % inhibition of TXA2 production by platelets at 30 minutes (Heavey et al., 
1985).  
 
Participants entered the climate controlled chamber (mean [SD] Tdb: 30.3 [0.9] °C, Twb: 22.9 [0.9] °C, 
WBGT: 25.1 [0.9] °C) removed their socks and shoes and rested in a semi-recumbent position for 25 
minutes whilst being instrumented. A laser Doppler probe (VP1T / 7, Moor Instruments, UK) was 
applied to the Great toe of the right foot using double sided adhesive rings to measure skin blood flow 
using a laser Doppler flowmetry monitor (moorVMS-LDF, Moor Instruments, UK). Laser Doppler 
data were recorded using a data acquisition system and software (Powerlab and LabChart 7, AD 
Instruments, New Zealand). A thermistor (Type EUS-U, Grant Instruments, UK) was applied to the 
medial aspect of the Great toe pad of the right foot using a single piece of adhesive tape. Tsk was 
measured using a squirrel 1200 series data logger (Grant Instruments, UK) and recorded every five 
seconds.  
 
Following the 25-minute rest period participants placed their right foot into a plastic bag and 
immersed it up to the point of the mid-malleoli into a stirred water bath (Grant Instruments, UK) 
maintained at 35.0 (0.3) °C for five minutes. Following this, participants removed their foot, still 
within the plastic bag, and immediately placed it in a stirred water bath maintained at 8.2 (0.1) °C for 
a further 30 minutes. After foot cooling, participants removed their foot from the water bath and 
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plastic bag to allow spontaneous rewarming of the foot for 15 minutes. Following this, participants 
were given 150 mL of diluted orange squash with or without soluble aspirin (300 mg). The reason for 
adding an extra dose of aspirin is due to the return of endothelial COX function within 90 minutes and 
to ensure that COX function was inhibited as much as possible (Heavey et al., 1985). If a participant 
received aspirin at the beginning of the protocol they also received aspirin in their second drink; if the 
participant was not given aspirin in their first drink, then they were not given aspirin in their second 
drink (Fig. 1). 
 
Within the next 25 minutes participants were instrumented for their hand immersion protocol. A laser 
Doppler probe and skin thermistor were placed onto participant‟s middle and second finger, 
respectively, of the right hand. Participants then placed their hand into a plastic bag and immersed it 
to the styloid process in a water bath maintained at 35.0 (0.2) °C for five minutes. The protocol for the 
hand was the same as for the foot in that cooling (8.1 [0.1] °C) and spontaneous rewarming followed. 
Blood pressure was measured from the left arm, using an automated monitor (Minimon 7137 Plus, 
Kontron Instruments, UK), for both the foot and hand cooling protocols and recorded two minutes 
prior to cooling, 30 seconds, five and 15 minutes into cooling, followed by 30 seconds and five 
minutes into rewarming. 
 
Participants' height and mass was measured using a stadiometer (Leicester, Bodycare, UK) and digital 
weighing scales (Ohaus I-10, Ohaus Corporation, USA), respectively. Length of participants' hand 
and foot was measured using a segmometer (Segmometer 4, Rosscraft, Canada). Hand and foot 
volume was calculated using a water displacement method. 
 
DATA ANALYSES 
As mean arterial pressure (MAP = ((2*diastolic)+systolic) / 3) differed over time (see results), skin 
blood flow was calculated as cutaneous vascular conductance (CVC) (laser Doppler units / MAP = 
CVC (flux•mmHg-1)). Tsk was plotted every five minutes and, from the sampled data which was 
recorded every five seconds, the CIVD variables were determined which included: average Tsk, 
minimum Tsk, number of CIVD waves, onset time of first CIVD wave, Tsk prior to onset of first CIVD 
wave and maximum Tsk during the first CIVD wave and amplitude of CIVD wave (Fig. 2). For the 
skin blood flow assessment during local cooling and rewarming, average, minimum and area under 
the curve (AUC, calculated using GraphPad, Version 5, USA) were calculated. 
 
Statistical analyses were conducted using IBM SPSS for Windows version 20 (IBM SPSS Statistics, 
USA). Data was assessed for normality with a Shapiro-Wilk test. An α of 0.05 was used to determine 
statistical significance. Participant characteristics were analysed using an independent samples t-test. 
MAP throughout immersion was analysed between- and within-groups with a repeated measures 
  
 
This article is protected by copyright. All rights reserved. 
8 
 
ANOVA to identify any differences in blood pressure between ethnicities and between COX 
inhibition and placebo. Where a significant main effect was observed (see results), pairwise 
comparisons were carried out and adjusted for multiple comparisons using the Holm-Bonferroni 
procedure.  
 
Baseline CVC (i.e. final minute of warm water immersion) between- and within-groups was analysed 
using an independent and paired samples t-test, respectively. Baseline Tsk (i.e. final five seconds of 
warm water immersion) between- and within-groups was analysed using a Mann-Whitney U test and 
a Wilcoxon Signed Rank test, respectively. CIVD variables, CVC average, minimum and AUC during 
cooling and rewarming between-groups were analysed using either an independent samples t-test or a 
Mann-Whitney U test. The same variables within-groups were analysed using a paired samples t-test 
or a Wilcoxon Signed Rank test. Between- and within-groups CVC and Tsk throughout immersion was 
analysed using a Mann-Whitney U and Wilcoxon Signed Rank Test, respectively, and adjusted for 
multiple comparisons using the Holm-Bonferroni procedure.  
 
Parametric data in text is presented as mean (SD) with non-parametric data presented as median and 
interquartile range (IQR). Figures shown are presented as mean (SD). Effect sizes, where appropriate, 
were calculated and are denoted by d for parametric data and r for non-parametric data. 
 
RESULTS 
PARTICIPANTS 
All participant characteristics were similar (P > 0.05), except AFD had a longer hand length (P = 
0.018, d = 1.04) and a greater hand volume (P = 0.043, d = 0.87) than CAU. 
 
MEAN ARTERIAL PRESSURE 
There was no main effect for ethnicity or condition (i.e. placebo vs. COX inhibition) for both foot or 
hand immersion protocols (mean [SD], baseline placebo, foot, CAU: 83 [5] mmHg, AFD: 83 [7] 
mmHg; hand, CAU: 82 [7] mmHg, AFD: 81 [8] mmHg, P > 0.05). However, there was a main effect 
for time for both the foot (P < 0.001) and hand (P = 0.022) protocol with pairwise comparisons 
showing MAP being elevated for the first five minutes of immersion in the foot protocol only (Table 
2). There was no statistical interaction between condition, time and ethnicity for both immersion 
protocols (P > 0.05). 
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BASELINE SKIN BLOOD FLOW AND SKIN TEMPERATURE 
Following COX inhibition, CAU had lower baseline toe CVC (Table 3, P = 0.019, d = 1.03) and Tsk 
(Table 3, P = 0.045, r = 0.41) than AFD. Otherwise, baseline values were similar (Table 3). 
 
FOOT RESPONSES TO COOLING AND SUBSEQUENT REWARMING 
SKIN BLOOD FLOW 
Toe skin blood flow during foot cooling and rewarming was similar between- and within-groups 
following placebo and COX inhibition (Table 4, Fig. 3A, P > 0.05). 
 
SKIN TEMPERATURE 
There was a tendency for CAU to have a lower average Tsk compared with AFD following COX 
inhibition (Table 5, P = 0.052, d = 0.84). Following placebo, only two CAU and four AFD 
experienced CIVD. Following COX inhibition, only two CAU and seven AFD experienced CIVD. 
Therefore, analyses on these variables could not be conducted.  
 
Toe Tsk during foot cooling and rewarming was similar between- and within-groups following placebo 
and COX inhibition (Fig. 3B, P > 0.05). 
 
FINGER RESPONSES TO COOLING AND SUBSEQUENT REWARMING 
SKIN BLOOD FLOW 
During cooling, COX inhibition resulted in a higher minimum CVC in AFD compared with placebo 
(Table 6, P = 0.039, d = 0.78). During cooling, following placebo, minimum CVC was lower in AFD 
compared with CAU (P < 0.001, d = 2.03) whilst there was a tendency for average CVC (P = 0.050, d 
= 0.84) and AUC (P = 0.053, d = 0.83) to be lower in AFD compared with CAU. During rewarming 
AFD had lower average CVC (P = 0.009, d = 1.17) and AUC (P = 0.009, d = 1.18) compared with 
CAU.  
 
During cooling, following COX inhibition, there was a tendency for average CVC (P = 0.052, d = 
0.85) and AUC (P = 0.055, d = 0.84) to be lower in AFD compared with CAU. During rewarming 
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AFD experienced a lower average CVC (P < 0.001, d = 1.69), minimum CVC (P = 0.017, d = 1.05) 
and AUC (P = 0.001, d = 1.63) compared with CAU.  
 
During cooling and subsequent rewarming finger skin blood flow was lower in AFD than CAU 
following both placebo and COX inhibition (Fig. 4A).  
 
SKIN TEMPERATURE 
For CAU, COX inhibition resulted in a warmer average finger Tsk (Table 7, P = 0.049, r = 0.28) and a 
faster onset time of CIVD (P = 0.035, r = 0.13) compared with placebo. Minimum finger Tsk was 
lower in AFD compared with CAU following both placebo (P = 0.004, d = 1.30) and COX inhibition 
(P = 0.034, d = 0.92). 
 
Finger Tsk during cooling and rewarming was lower in AFD compared with CAU following both 
placebo and COX inhibition (Fig. 4B). 
 
DISCUSSION 
The primary findings of this study were 1) during foot cooling, toe skin blood flow (Fig. 3A) and Tsk 
(Fig. 3B) did not differ between ethnic groups irrespective of COX inhibition, and 2) during local 
hand cooling AFD experienced significantly lower finger skin blood flow (Fig. 4A) and Tsk (Fig. 4B) 
compared with CAU irrespective of COX inhibition. Following placebo, the present study confirms 
previous findings between CAU and AFD in response to hand cooling (Iampietro et al., 1959; 
Newman, 1969; Jackson et al., 1989; Maley et al., 2014), whilst the responses to foot cooling (8 °C 
for 30 minutes) are the first to be reported here. Contrary to our hypothesis these data suggest that in 
young AFD healthy males the COX pathway appears not to be the primary reason for the increased 
susceptibility to NFCI. 
 
During foot cooling AFD responded in a comparable manner to CAU. Given that NFCI is more 
prominent in the feet and AFD are more susceptible to NFCI, it was expected that CAU would 
respond to foot cooling with warmer Tsk and greater skin blood flow responses compared with AFD. 
The authors are not sure why no ethnic differences were observed in the direction expected. Thickness 
in skin may be a contributing factor as the authors noted that the skin on the sole of the foot in African 
descent participants felt „thicker‟. Whilst the stratum corneum thickness is similar between African 
and European individuals on skin sites such as the hip, arm and face (Thomson, 1955; Freeman et al., 
1962; Richards et al., 2003), the deeper dermis layer is thicker in AFD (Richards et al., 2003). If the 
skin (epidermis or dermis) is thicker on the sole of the foot in African individuals then this may have 
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provided some protection (insulation) from the cold stimulus and hidden a dysfunctional 
microvascular response. Stratum corneum thickness has been discussed previously as a factor that 
may influence finger cooling rates (Jay & Havenith, 2004). However, as previously observed (Maley 
et al., 2014), it is possible that AFD do not experience a dysfunctional response to local foot cooling 
without centrally-driven vasoconstriction. 
 
Interestingly, during foot cooling some participants experienced a very strong local vasoconstrictor 
response, whilst other exhibited only slight changes. The reason for the variability is not known. 
Individuals born in a tropical climate may experience exaggerated responses to local finger cooling 
(Lee et al., 2013), however eight out of the 12 participants in this study were born in the UK, with the 
four born outside the UK not primarily responsible for the variability. While participants reported 
similar exposure to cold, other factors, such as differences in deep body temperature (Daanen et al., 
1997) and physical fitness (Keramidas et al., 2010), may have contributed to the variability in 
responses. 
 
The present study does not lend support to a previous pilot study (Belvins et al., 2014) where it was 
suggested that COX inhibition in CAU may facilitate local skin blood flow during foot cooling and 
spontaneous rewarming. The present study employed a colder water temperature (8 °C vs. 15 °C) and 
one immersion of 30 minutes in comparison to three repeated immersions of ten minutes in the pilot 
study. Different cooling rates and duration between the two studies may have contributed to 
confliction in results, however further elaboration of differences between studies is not possible at 
present given the little information available.  
 
Using forearm and finger venous occlusion plethysmography, previous research has demonstrated the 
reflex vascular responses to arm or foot cooling are not altered by COX inhibition (Cowley et al., 
1983, 1985; Gresele et al., 1985; Hechtman & Jageneau, 1985), with one study demonstrating an 
increase in vascular resistance during foot cooling (Serneri et al., 1981). As the present study 
observed the local vascular response (using laser Doppler flowmetry) to local cooling, the results are 
difficult to compare to previous studies as reflex vasoconstriction is controlled differently to local 
vasoconstriction (Johnson et al., 2014).  
 
As hypothesised, during hand immersion, the fingers of AFD reached a lower temperature and 
rewarmed more slowly than CAU, confirming our previous findings (Maley et al., 2014). We also 
hypothesised that COX inhibition in AFD would result in warmer finger Tsk during hand cooling and 
spontaneous rewarming making their response similar to CAU, although this did not occur. As 
alluded to within the introduction, we hoped that COX inhibition would attenuate the production of 
ROS and in turn reduce the vasoconstriction experienced by AFD during local hand cooling. 
However, the present study appears to provide evidence that COX is not the major cause for the 
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greater vasoconstrictor response and cooler Tsk to local hand cooling in AFD. The authors can only 
speculate that other sources of oxidative stress, such as NADPH oxidase (Griendling & FitzGerald, 
2003), are partly responsible for the exaggerated responses experienced by AFD. Anti-oxidants 
capable of scavenging oxygen-derived free radicals prior to cooling should be investigated in future 
studies.  
  
Despite COX inhibition not providing any advantage to AFD during local hand cooling, it was noted 
that CAU experienced a warmer average finger Tsk and earlier CIVD onset time (Table 7) following 
COX inhibition versus placebo. The difference in average finger Tsk was 0.6 °C and only four 
participants were included in the analyses for the CIVD onset time, therefore caution should be 
exercised when interpreting the present results. Additionally, it should be noted that COX inhibition 
use (e.g. acetaminophen) prior to whole-body cooling may lead to a faster decline in deep body 
temperature (Foster et al., 2016). While COX inhibition may produce warmer finger Tsk during local 
cooling, the authors do not recommend administering aspirin, or any other COX inhibitor, to an 
individual susceptible to NFCI. 
 
Factors other than local cutaneous vasculature control may play a role in the increased susceptibility 
to NFCI in AFD. Previous research has shown AFD compared with CAU experience a lower deep 
body temperature, finger Tsk and oxygen uptake during whole-body cooling (Rennie & Adams, 1957; 
Adams & Covino, 1958; Farnell et al., 2008). Given that the CIVD responses are blunted with colder 
environments / lower deep body temperatures (Keatinge, 1957; Sawada et al., 2000; Dobnikar et al., 
2009) it is possible that factors such as thermogenesis and / or centrally-driven vasoconstriction, in 
combination with a depressed CIVD reaction (at least in the hands) during whole-body cooling may 
play a role in the increased susceptibility to NFCI in AFD. Further studies are being conducted to 
elucidate the extremity vascular responses to whole-body cooling between CAU and AFD.  
 
It is concluded that young, healthy, male AFD and CAU show similar physiological responses to foot 
cooling. In contrast, compared with CAU, AFD experience lower finger skin blood flow and cooler 
finger Tsk in response to hand cooling irrespective of COX inhibition. Therefore, it is unlikely that the 
COX pathway is responsible for the increased susceptibility to NFCI in AFD.  
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TABLES 
Table 1. Mean (SD) participant characteristics  
 Participant Characteristics 
 CAU AFD 
Age (years) 20 (4) 20 (2) 
Height (cm) 178.2 (6.9) 176.0 (7.9) 
Mass (kg) 73.1 (12.3) 74.1 (12.8) 
Hand Length (cm) 20.0 (1.1)* 21.2 (1.2) 
Foot Length (cm) 26.3 (1.2) 27.0 (1.8) 
Hand Volume (L) 0.42 (0.12)* 0.53 (0.13) 
Foot Volume (L) 1.16 (0.19) 1.24 (0.32) 
* Significant difference between CAU and AFD (P < 0.05). n = 12 for each group. 
 
Table 2. Mean (SD) mean arterial pressure (mmHg) for the foot and hand protocol as an average of both ethnic 
groups in both placebo and COX inhibition trials 
 Mean Arterial Pressure (mmHg) 
Time Foot Hand 
Baseline 83 (7) 82 (8) 
30 seconds cooling 88 (9)* 84 (9) 
5 minutes cooling 87 (9)* 86 (9) 
15 minutes cooling 84 (6) 85 (7) 
30 seconds rewarming 85 (8) 83 (8) 
5 minutes rewarming 82 (7) 82 (7) 
* Significant difference compared with baseline (P < 0.05). 
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Table 3. Mean (SD) or median (IQR) toe and finger cutaneous vascular conductance (flux•mmHg-1) and skin 
temperature (°C) at the end of warm water immersion for the foot and hand protocol following placebo or COX 
inhibition 
 Baseline Cutaneous Vascular Conductance (flux•mmHg-1) 
 Placebo COX inhibition 
Skin site CAU AFD CAU AFD 
Toe 2.2 (1.7) 3.1 (1.1) 1.8 (1.5)* 3.4 (1.7) 
Finger 4.7 (0.8) 4.8 (1.0) 4.3 (1.2) 5.1 (1.1) 
 Baseline Skin Temperature (°C) 
Toe ^ 35.1 (1.1) 35.6 (1.2) 34.8 (1.6)* 35.5 (0.6) 
Finger ^ 35.9 (0.4) 35.8 (0.2) 35.8 (0.2) 35.8 (0.1) 
^ Median (IQR). * Significant difference between CAU and AFD (P < 0.05). n = 12 for each group. 
 
Table 4. Mean (SD) or median (IQR) cutaneous vascular conductance (flux•mmHg-1) variables for the toe skin site 
during foot cooling and rewarming following placebo and COX inhibition 
  Cutaneous Vascular Conductance (flux•mmHg-1) 
  Placebo COX inhibition 
  CAU AFD CAU AFD 
Cooling 
Average 1.6 (1.7) 1.7 (1.4) 1.3 (1.3) 2.3 (1.6) 
Minimum ^ 0.2 (0.6) 0.2 (0.4) 0.1 (0.2) 0.2 (0.7) 
AUC 49 (51) 55 (43) 40 (39) 70 (51) 
Rewarming 
Average ^ 1.2 (2.8) 1.5 (2.9) 1.5 (2.3) 1.5 (3.6) 
Minimum ^ 0.2 (1.2) 0.2 (0.6) 0.3 (0.3) 0.4 (2.3) 
AUC 25 (23) 27 (22) 25 (22) 32 (32) 
^ Median (IQR). AUC = Area under the curve. n = 12 for each group. 
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Table 5. Mean (SD) or median (IQR) cold-induced vasodilatation variables for the toe skin site during the foot 
cooling protocol following placebo and COX inhibition 
 Placebo COX inhibition 
 CAU AFD CAU AFD 
Average Tsk (°C) 14.4 (3.4) 15.9 (4.1) 13.7 (3.1)† 16.4 (3.3) 
Minimum Tsk (°C) ^ 9.3 (4.1) 10.9 (7.8) 9.1 (2.4) 12.6 (6.6) 
 CAU (n = 2) AFD (n = 4) CAU (n = 2) AFD (n = 7) 
Number of waves 1.0 (0.0) 1.5 (0.6) 1.5 (0.7) 1.6 (0.5) 
Onset time (min) 19.3 (4.0) 3.6 (0.8) 4.8 (3.3) 4.9 (3.6) 
Tsk prior to onset of CIVD (°C) 14.0 (5.1) 19.9 (1.8) 19.6 (0.7) 18.1 (2.4) 
Max Tsk during CIVD (°C) 15.7 (5.2) 22.5 (2.1) 21.2 (1.4) 20.5 (2.0) 
Amplitude (°C) 1.7 (0.1) 2.7 (0.4) 1.7 (0.6) 2.4 (1.6) 
† P = 0.052. ^ Median (IQR). n = 12 for average and minimum Tsk. 
 
Table 6. Mean (SD) cutaneous vascular conductance variables for the finger skin site during hand cooling and 
rewarming following placebo and COX inhibition 
  Cutaneous Vascular Conductance (flux•mmHg-1) 
  Placebo COX inhibition 
  CAU AFD CAU AFD 
Cooling 
Average 2.1 (0.9) 1.4 (0.8) 2.3 (1.1) 1.6 (0.6) 
Minimum 0.8 (0.2)* 0.5 (0.1)‡ 0.9 (0.5) 0.6 (0.3) 
AUC 66 (27) 44 (24) 74 (35) 50 (18) 
Rewarming 
Average 4.3 (1.0)* 2.8 (1.6) 4.3 (0.6)* 2.8 (1.0) 
Minimum 1.5 (0.6) 1.2 (1.1) 1.6 (0.8)* 0.9 (0.5) 
AUC 66 (16)* 43 (24) 66 (10)* 45 (16) 
* Significant difference between CAU and AFD (P < 0.05). ‡ Significant difference between placebo and COX 
inhibition (P < 0.05). AUC = Area under the curve. n = 12 for each group. 
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Table 7. Mean (SD) or median (IQR) cold-induced vasodilatation variables for the finger skin site during the hand 
cooling protocol following placebo and COX inhibition 
 Placebo COX inhibition 
 CAU AFD CAU AFD 
Average Tsk (°C) 14.6 (2.3)‡ 13.0 (3.0) 15.2 (2.5) 13.5 (1.9) 
Minimum Tsk (°C) 10.7 (1.3)* 9.5 (1.4) 10.4 (0.9)* 9.5 (1.2) 
 CAU (n = 7) AFD (n = 4) CAU (n = 4) AFD (n = 5) 
Number of waves ^ 1.0 (1.0) 1.0 (0.0) 2.0 (1.5) 1.0 (0.5) 
Onset time (min) 9.7 (6.2)‡ 10.7 (8.5) 6.1 (5.9) 7.3 (5.6) 
Tsk prior to onset of CIVD (°C) 13.8 (4.3) 14.1 (4.2) 15.8 (6.2) 14.9 (4.4) 
Max Tsk during CIVD (°C) 17.5 (6.2) 19.1 (3.8) 19.3 (5.6) 18.2 (5.1) 
Amplitude (°C) 3.6 (2.3) 5.0 (1.4) 3.5 (3.3) 3.3 (1.0) 
^ Median (IQR). * Significant difference between CAU and AFD (P < 0.05). ‡ Significant difference between 
placebo and COX inhibition (P < 0.05). n = 12 for average and minimum Tsk. 
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FIGURE CAPTIONS 
 
Figure 1. Schematic of the experimental procedure 
 
Figure 2. Typical trace of finger skin temperature (°C) during hand immersion in water at 8 °C and subsequent 
rewarming in air at 30 °C showing variables analysed during cold-induced vasodilatation.  
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Figure 3. Mean (SD) toe cutaneous vascular conductance (flux•mmHg-1) (a) and skin temperature 
(°C) (b) during foot cooling and subsequent spontaneous rewarming following placebo and COX 
inhibition 
Note: SD included for CAU Placebo protocol only for reader clarity. 
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Figure 4. Mean (SD) finger cutaneous vascular conductance (flux•mmHg-1) (a) and skin temperature 
(°C) (b) during hand cooling and subsequent spontaneous rewarming following placebo and COX 
inhibition 
* Significant difference between CAU and AFD following placebo (P < 0.05). † Significant difference between 
CAU and AFD following COX inhibition (P < 0.05). Note: SD included for CAU Placebo protocol only for 
reader clarity. 
 
